Silexion Therapeutics* (NASDAQ: SLXN) is making strides in oncology with its RNAi-based treatment, SIL-204, targeting KRAS-driven cancers. In an interview on Market Leaders, CEO Ilan Hadar discussed the company’s recent…
Posts published in “Global Markets News”
This Article Contains Promotional Content on behalf of Beyond Oil. Beyond Oil* (CSE: BOIL) (OTCQB: BEOLF), an innovative food-tech company, announced a transformative 5 year distribution agreement with Latitude with…
This Article Contains Promotional Content on behalf of Beyond Oil. In a major development for Beyond Oil (CSE: BOIL, OTCQB: BEOLF, Frankfurt: UH9)*, the food-tech company has announced a landmark…
Cipia, a global leader in in-cabin sensing solutions, has unveiled a significant upgrade to its fleet safety product, Cipia-FS10. The company has added Advanced Driver Assistance System (ADAS) features to…
This Article Contains Promotional Content on behalf of Beyond Oil. In a significant step towards its global expansion strategy, Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9), a food-tech…
Actelis Networks (NASDAQ: ASNS), a company long recognized for its hybrid-fiber networking technology, has taken a significant leap into the realm of infrastructure security with the launch of MetaShield. This…
As the technology advances one major challenge that seems to have persisted throughout the years is vehicle safety, specifically, ensuring driver attentiveness and in-cabin safety. In fact, these factors have…
This Article Contains Promotional Content on behalf of Beyond Oil. Beyond Oil Ltd (CSE: BOIL) (OTCQB: BEOLF) recently announced it had raised C$1.77 million through the exercise of over 1.4…
Actelis Networks, a leader in cyber-hardened, rapid deployment networking solutions for wide-area IoT applications, reported a stellar performance in its Q3 2024 financial results, achieving a 200% year-over-year revenue increase.…
Nuvectis Pharma (NASDAQ: NVCT) has reported encouraging interim data from its Phase 1b study of NXP800, a drug candidate designed to treat platinum-resistant, ARID1a-mutated ovarian cancer. This type of cancer…